Trade Summary

Yesterday, Lippis Daniel J., serving as CVP, TAVR at Edwards Lifesciences Corp (EW), sold 619 shares at $91.40 per share, for a total transaction value of $56,576.72. Following this transaction, Lippis Daniel J. now holds 40,411 shares of EW.

This sale represents a 1.51% decrease in Lippis Daniel J.'s stake in the company. This is considered a medium-conviction trade.

The trade was executed on Tuesday, June 30, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, July 1, 2026 (accepted Jun 30, 8:01 PM ET), 1 day after the trade was made.

Edwards Lifesciences Corp operates in the HEALTHCARE sector, specifically within the MEDICAL DEVICES industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.